Clinical Experience With Regenerative Therapy in Heart Failure: Advancing Care With Cardiopoietic Stem Cell Interventions.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29748365.
- Also identified by DOI 10.1161/CIRCRESAHA.118.312753 and PMC identifier 6089255.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Adoption of regenerative strategies for heart failure is challenged by mixed outcomes in clinical trials. Ongoing development plans strive to improve biotherapeutic potency, optimize delivery, standardize dosing, and target responsive patient populations. The Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART) program offers advanced experience in clinical development of next generation regenerative therapies.
Medical subject headings
- Heart Failure
- Regenerative Medicine
- Stem Cell Transplantation